Note 9 - Segment Information

6 Months Ended

Dec. 31, 2013

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

Note 9. Segment Information

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company’s operating segments.

The Company has divided its operations into three reportable segments as follows: Contract Manufacturing, Branded Proprietary Products and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe and Canada, for the three months ended December 31, 2013 and 2012 were $3,170 and $3,125, respectively and for the six months ended December 31, 2013 and 2012 were $6,256 and $5,643, respectively.

Financial information relating to the three months ended December 31, 2013 and 2012 operations by business segment are as follows:

		Sales, Net						Segment
		U.S. Customers		International Customers		Total		Gross Profit		Depreciation		Capital Expenditures
Contract Manufacturing	2013	$	4,973	$	2,819	$	7,792	$	1,208	$	63	$	103
	2012		3,521		2,709		6,230		841		66		-
Branded  Proprietary Products	2013		130		322		452		107		1		-
	2012		403		391		794		222		1		-
Other Nutraceutical Businesses	2013		515		29		544		154		2		2
	2012		346		25		371		76		4		-
Total Company	2013		5,618		3,170		8,788		1,469		66		105
	2012		4,270		3,125		7,395		1,139		71		-

Financial information relating to the six months ended December 31, 2013 and 2012 operations by business segment are as follows:

		Sales, Net						Segment
		U.S. Customers		International Customers		Total		Gross Profit		Depreciation		Capital Expenditures
Contract Manufacturing	2013	$	10,402	$	5,681	$	16,083	$	2,574	$	129	$	103
	2012		8,397		4,913		13,310		1,937		132		8
Branded Proprietary Products	2013		262		482		744		164		1		-
	2012		990		635		1,625		544		5		-
Other Nutraceutical Businesses	2013		1,059		93		1,152		328		5		2
Businesses	2012		845		95		940		223		7		-
Total Company	2013		11,723		6,256		17,979		3,066		135		105
	2012		10,232		5,643		15,875		2,704		144		8

	Total Assets as of
	December 31, 2013		June 30, 2013
Contract Manufacturing	$	7,293	$	8,524
Branded Proprietary Products		2,125		2,186
Other Nutraceutical Businesses		2,348		1,901
Total Company	$	11,766	$	12,611